BIO International 2025 Recap: Why Relationship-Driven Growth Is Winning in Life Sciences
By Alex Halstead, Director of Business Development – Life Sciences, Hobson Associates
After spending a packed few days at BIO International 2025 in Boston, one thing is clear: the market has shifted—and so have the strategies that win.
Across conversations with CDMOs, CROs, diagnostics firms, and leaders in pharma services and biotech platforms, the same themes kept emerging. Companies that are thriving in today’s market aren’t relying on volume or speed alone. Instead, they’re leaning into something deeper: relationship-driven partnering.
The Market Reality in 2025
Too many companies are still waiting for the market to “feel like 2021” again—
When capacity sold itself.
When growth was fast and frictionless.
When speed trumped alignment.
But here’s the reality today: